DESCRIPTION provided by applicant The high failure rate of drugs in late stage development nearly is a symptom of the inadequacy of pre clinical animal models to accurately predict human biol ...SBIR Phase I 2016 Department of Health and Human Services National Institutes of Health
DESCRIPTION provided by applicant Only of investigational drugs that enter clinical trials make it to approval Seventy five percent of these failures are due to either unexpected toxicity or l ...SBIR Phase I 2015 Department of Health and Human Services National Institutes of Health
DESCRIPTION (provided by applicant): The first isolated human hepatoctyte 2D culture, in 1981, provided baseline protocols to support freshly isolated and immediately cultured populations. With cryopr ...SBIR Phase I 2011 Department of Health and Human Services
SCIKON INNOVATION, INC.
| 2 Davis Drive / FFVC
RESEARCH TRIANGLE PARK, NC, 27709-0003
|Socially and Economically Disadvantaged:||N|
|Number of Employees:||1|